Contribution By Pankaj Singh
The global biphenyl industry is gaining traction and it is expected to grow substantially over the next few years. Current trends in the industry are being driven by the ongoing developments in the chemical sector. The need to enhance crop yield in o
Hutchison China MediTech Ltd. (Chi-Med), a Hong Kong-based leading innovative biopharmaceutical firm, has reportedly partnered with Inmagene Biopharmaceuticals (Inmagene) in a bid to further develop its four new preclinical drug candidates for the tr
Plug Power Inc., an electrical equipment manufacturing company, and SK Group, a conglomerate company, have recently announced plans to enter a strategic partnership. The deal is aimed at accelerating the use of hydrogen as an alternative source of en
One of the leading intelligent processor suppliers Kalray and France-based EasyMile have reportedly strengthened their relationship with the signature of an MoU (Memorandum of Understanding) formalizing their collaboration to jointly develop intellig
In a bid to cater to the growing demand for healthy alternatives, Chipotle Mexican Grill Inc., an American chain of fast-casual restaurants, has reportedly introduced a cilantro-lime cauliflower rice bowl that will be compliant with its Vegetarian, K
China-based ophthalmic pharmaceutical company Ocumension Therapeutics has reportedly made a 15.7 million investment in EyePoint Pharmaceuticals Inc., a United States-based company that focuses on developing innovative therapeutics for eye disorders.
Japan’s renewable energy sector got major boost recently when the nation announced plans to phase out petrol-based cars and decrease battery costs to become carbon-neutral become by 2050.
Under the leadership of Japan’s Prime Minister Yo
Ameresco, Inc., a leading renewable energy company, has recently completed a plant-wide energy efficiency project. This project was developed in partnership with the Mattabassett District in Connecticut.
Under the ESA (energy services agreement), th
The Serum Institute of India (SII), the Pune-based manufacturer of immunobiological drugs and vaccines, has reportedly approached DCGI (Drugs Controller General of India) to seek emergency use authorization for its COVID-19 vaccine in India.